FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2795111036> ?p ?o ?g. }

• W2795111036 endingPage "519" @default.
• W2795111036 startingPage "511" @default.
• W2795111036 abstract "Study Objective To determine the influence of anticholinergic medications on transitions in cognitive diagnosis of older adults in primary care. Design This observational cohort study was conducted over a mean follow‐up of 3.2 years. Anticholinergic exposure was defined by pharmacy dispensing and claims records. Cognitive diagnosis was performed by an expert panel at baseline and annually up to 4 years. Data Source Medication exposure and other clinical data were extracted from the Indiana Network for Patient Care (INPC). The cognitive diagnosis was derived from a cognitive screening and diagnosis study. Participants A total of 350 adults 65 years and older without dementia and receiving primary care in a safety net health care system. Measurement and Main Results Cognitive diagnosis followed a two‐phase screening and consensus‐based neuropsychiatric examination to determine a baseline diagnosis as normal cognition, mild cognitive impairment (MCI), or dementia, with a follow‐up neuropsychiatric examination and consensus‐based diagnosis repeated annually. The Anticholinergic Cognitive Burden scale was used to identify anticholinergics dispensed up to 10 years before enrollment and annually throughout the study. A total standard daily dose of anticholinergics was calculated by using pharmacy dispensing data from the INPC. Among 350 participants, a total of 978 diagnostic assessments were completed over a mean follow‐up of 3.2 years. Compared with stable cognition, increasing use of strong anticholinergics calculated by total standard daily dose increased the odds of transition from normal cognition to MCI (odds ratio [OR] 1.15, 95% confidence interval [CI] 1.01–1.31, p = 0.0342). Compared with stable MCI, strong anticholinergics did not influence the reversion of MCI to normal cognition (OR 0.95, 95% CI 0.86–1.05, p = 0.3266). Conclusion De‐prescribing interventions in older adults with normal cognition should test anticholinergics as potentially modifiable risk factors for cognitive impairment." @default.
• W2795111036 created "2018-04-06" @default.
• W2795111036 creator A5019055956 @default.
• W2795111036 creator A5024992400 @default.
• W2795111036 creator A5033229729 @default.
• W2795111036 creator A5039635718 @default.
• W2795111036 creator A5049840158 @default.
• W2795111036 date "2018-04-25" @default.
• W2795111036 modified "2023-10-18" @default.
• W2795111036 title "Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care" @default.
• W2795111036 cites W1512373410 @default.
• W2795111036 cites W1568390176 @default.
• W2795111036 cites W1967464880 @default.
• W2795111036 cites W1973276273 @default.
• W2795111036 cites W1977892449 @default.
• W2795111036 cites W2014560168 @default.
• W2795111036 cites W2022365852 @default.
• W2795111036 cites W2034252538 @default.
• W2795111036 cites W2043743433 @default.
• W2795111036 cites W2044191942 @default.
• W2795111036 cites W2044589919 @default.
• W2795111036 cites W2061114904 @default.
• W2795111036 cites W2062706679 @default.
• W2795111036 cites W2070495958 @default.
• W2795111036 cites W2080265469 @default.
• W2795111036 cites W2090663532 @default.
• W2795111036 cites W2095755860 @default.
• W2795111036 cites W2113105425 @default.
• W2795111036 cites W2113460545 @default.
• W2795111036 cites W2122320288 @default.
• W2795111036 cites W2130997146 @default.
• W2795111036 cites W2139337687 @default.
• W2795111036 cites W2146593685 @default.
• W2795111036 cites W2158416913 @default.
• W2795111036 cites W2161226067 @default.
• W2795111036 cites W2162173660 @default.
• W2795111036 cites W2166487292 @default.
• W2795111036 cites W2168499550 @default.
• W2795111036 cites W2266408826 @default.
• W2795111036 cites W2335418062 @default.
• W2795111036 cites W2341378930 @default.
• W2795111036 cites W2529284522 @default.
• W2795111036 cites W2559732081 @default.
• W2795111036 cites W3014251530 @default.
• W2795111036 cites W4247938048 @default.
• W2795111036 cites W563373921 @default.
• W2795111036 doi "https://doi.org/10.1002/phar.2106" @default.
• W2795111036 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6036636" @default.
• W2795111036 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29600808" @default.
• W2795111036 hasPublicationYear "2018" @default.
• W2795111036 type Work @default.
• W2795111036 sameAs 2795111036 @default.
• W2795111036 citedByCount "44" @default.
• W2795111036 countsByYear W27951110362018 @default.
• W2795111036 countsByYear W27951110362019 @default.
• W2795111036 countsByYear W27951110362020 @default.
• W2795111036 countsByYear W27951110362021 @default.
• W2795111036 countsByYear W27951110362022 @default.
• W2795111036 countsByYear W27951110362023 @default.
• W2795111036 crossrefType "journal-article" @default.
• W2795111036 hasAuthorship W2795111036A5019055956 @default.
• W2795111036 hasAuthorship W2795111036A5024992400 @default.
• W2795111036 hasAuthorship W2795111036A5033229729 @default.
• W2795111036 hasAuthorship W2795111036A5039635718 @default.
• W2795111036 hasAuthorship W2795111036A5049840158 @default.
• W2795111036 hasBestOaLocation W27951110362 @default.
• W2795111036 hasConcept C104863432 @default.
• W2795111036 hasConcept C118552586 @default.
• W2795111036 hasConcept C126322002 @default.
• W2795111036 hasConcept C156957248 @default.
• W2795111036 hasConcept C169900460 @default.
• W2795111036 hasConcept C1862650 @default.
• W2795111036 hasConcept C187212893 @default.
• W2795111036 hasConcept C201903717 @default.
• W2795111036 hasConcept C2778689640 @default.
• W2795111036 hasConcept C2779134260 @default.
• W2795111036 hasConcept C2779483572 @default.
• W2795111036 hasConcept C2984863031 @default.
• W2795111036 hasConcept C44249647 @default.
• W2795111036 hasConcept C512399662 @default.
• W2795111036 hasConcept C6057870 @default.
• W2795111036 hasConcept C71924100 @default.
• W2795111036 hasConcept C72563966 @default.
• W2795111036 hasConceptScore W2795111036C104863432 @default.
• W2795111036 hasConceptScore W2795111036C118552586 @default.
• W2795111036 hasConceptScore W2795111036C126322002 @default.
• W2795111036 hasConceptScore W2795111036C156957248 @default.
• W2795111036 hasConceptScore W2795111036C169900460 @default.
• W2795111036 hasConceptScore W2795111036C1862650 @default.
• W2795111036 hasConceptScore W2795111036C187212893 @default.
• W2795111036 hasConceptScore W2795111036C201903717 @default.
• W2795111036 hasConceptScore W2795111036C2778689640 @default.
• W2795111036 hasConceptScore W2795111036C2779134260 @default.
• W2795111036 hasConceptScore W2795111036C2779483572 @default.
• W2795111036 hasConceptScore W2795111036C2984863031 @default.
• W2795111036 hasConceptScore W2795111036C44249647 @default.
• W2795111036 hasConceptScore W2795111036C512399662 @default.
• W2795111036 hasConceptScore W2795111036C6057870 @default.

• next